An in vitro study of triple negative breast cancer utilizing ChIP and next generation sequencing found that although there is some overlap with the AR cistrome in a prostate cancer cell line and ERα +ve MCF7 cells, a significant proportion of the AR binding sites are specific to cells which are ERα –ve Her2+ve (93). Here, ERBB2 is linked to triple-negative breast carcinoma.